Skip to content
DefDex

Federal award

ROCHE DIAGNOSTICS CORPORATION

W81K0021P0269

Contract

Obligated and Ceiling

Obligated (net)
$4,432,756.73
Ceiling (potential value, not spending)
$6,101,656.73
Current value
$4,432,756.73
Gross positive obligations
$6,675,600.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ROCHE HOLDING AG · WJHDT127L353
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0021P0269
Award type code
B
Actions
14 · Sep 2, 2021 to May 21, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
May 21, 2025FY2025P00013C−$625,893.39
—
May 13, 2025FY2025P00012C−$81,045.67
—
Apr 24, 2025FY2025P00011C−$817,004.21
—
Jan 3, 2025FY2025P00010C$1,668,900.00
—
Jul 11, 2024FY2024P00009G$0.00
—
Jun 28, 2024FY2024P00008C−$718,900.00
—
Nov 30, 2023FY2024P00007C$1,668,900.00
—
Aug 17, 2023FY2023P00006M$0.00
—
Apr 6, 2023FY2023P00005G$0.00
—
Nov 2, 2022FY2023P00004C$1,668,900.00
—
Aug 24, 2022FY2022P00003G$0.00
—
Jul 29, 2022FY2022P00002B$1,124,490.00
—
Dec 3, 2021FY2022P00001C$544,410.00
—
Sep 2, 2021FY20210—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.